Get ready to energize your life?
Top Offers Only Today
Support your health and step-up your mental focus
post in: Beauty Date:07 Oct 2017, 07:51 views:4840
A Diagnostic Challenge, aspirin allergies affect about 10 of adults with asthma. Bronx, NY - April 22, 2014 -. Mendez a 27-year-old healthy professional baseball player experienced a sudden asthma attack during a game.
He was intubated on the field and, after a week in the intensive care unit of a local hospital, was diagnosed with asthma and started on medication. A few weeks later, he took ibuprofen after a game to relieve pain and inflammation in his overworked muscles (a common practice among professional athletes). A few minutes later, he experienced another asthma attack and, following a 911 call, was again intubated.
His doctors advised him to quit baseball. After a period of unemployment and a move to the New York angina City area where he had family, he found a job as a golf course superintendent. He soon noticed that he could no longer taste food or smell anything.
Several allergists advised him to continue asthma medications and to use nasal sprays, none of which helped.
He then saw an otolaryngologist and was diagnosed with nasal polyps, removed by sinus surgery. Two months after the sinus surgery, his polyps grew back. At the age of 32, he was referred to the.
Montefiore Drug Allergy Center, where he was diagnosed with aspirin-exacerbated respiratory disease (aerd).
Elina Jerschow, MD, aERD affects about 10 percent of all adults with asthma and 40 percent of patients with asthma and nasal polyps. These patients are sensitive to aspirin and other non-steroidal anti-inflammatory drugs (nsaids, including ibuprofen and naproxen). The diagnosis of these patients generally happens through an oral-graded aspirin challenge, currently considered the gold-standard diagnostic test for patients with aspirin-exacerbated respiratory disease (aerd).
This method can induce asthma attacks in 40 to 85 of the people who undergo. A new study. Elina Jerschow seeks to develop a safer, quicker, more cost-efficient method of identifying aspirin-sensitive asthma, and to elucidate the underlying cause of aerd.